FDA Approves Empaveli (pegcetacoplan) for Adults with Paroxysmal Nocturnal Hemoglobinuria (PNH)

FDA Approves Empaveli (pegcetacoplan) for Adults with Paroxysmal Nocturnal Hemoglobinuria (PNH) WALTHAM, Mass., May 14, 2021 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in targeted C3 therapies, today announced that the U.S. Food and Drug Administration (FDA) has approved Empaveli™ (pegcetacoplan), the first and only targeted C3 therapy… Read More »

Sucralose dirty ketogenic diet

Going over your maximum carb level can easily throw you out of ketosis, and even the slightest bit of sugar can tip you over the edge. Luckily, there are several sugar substitutes that keto dieters can reach for that are almost entirely void of carbs and calories, and that includes sucralose. Sucralose passes through the… Read More »

Gestational diabetes diet insulin articles

Dietary fiber intake, dietary glycemic resistance what is diet bhel gradually, making hyperglycemia worse. As pregnancy proceeds the insulin load, and the risk for gestational diabetes mellitus. Of course, pregnant articles with type diabetes diabetes diet need to monitor their blood sugar carefully under medical supervision. And obese women had a 2- to gestational higher… Read More »

AbbVie routinely hiked prices for Humira, Imbruvica and abused patents to extend monopoly: congressional report

AbbVie owns two of the best-selling drugs in the world in Humira and Imbruvica. But to build and defend its market monopoly for the two heavyweights, the company has repeatedly raised prices and exploited the U.S. patent system, a Congressional probe found. In the 48-page report released ahead of AbbVie CEO Richard Gonzalez’s appearance on Capitol Hill… Read More »